Michael Winlo says there is a gap in the market for companies researching the effectiveness of medicinal cannabis. Photo: Gabriel Oliveira.

Emerald targets green medicine growth

With mainstream acceptance for cannabinoid medicines growing, Emerald Clinics has found value in building clinical evidence of its use.


(existing subscribers)

The password field is case sensitive.
Request new password

Add your comment

BNiQ Disclaimer